Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
INTUITIVE SURGICAL INC
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-79.7% vs price
Base Case (Median)
-72.3% vs price
Bull Case (75th pct.)
-54.8% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $83.45 | -81.3% | High (40%) |
| PE Comparable | $187.52 | -57.9% | Medium (25%) |
| Growth Trajectory DCF | $239.05 | -46.4% | Medium (20%) |
| Graham Number | $97.37 | -78.1% | Medium (40%) |
| EV/EBITDA | $123.44 | -72.3% | Medium (20%) |
| EV/FCF | $215.35 | -51.7% | Medium (20%) |
| Earnings Power Value | $64.98 | -85.4% | Medium (50%) |
Based on 7 out of 7 methods, ISRG appears overvalued at the current price of $445.58. The base case fair value of $123.44 implies 72.3% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.